Exenatide Patent Application Refusal Case: The Delhi High Court Judgment
This case highlights how the exenatide patent filed by Amylin Pharmaceuticals led to a detailed examination of inventive step, therapeutic efficacy, and Section 3(d) objections, culminating in a significant Delhi High Court judgment in Nov. 2025